Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis

  • Al Khleifat, Ahmad
  • Iacoangeli, Alfredo
  • van Vugt, Joke J F A
  • Bowles, Harry
  • Moisse, Matthieu
  • Zwamborn, Ramona A J
  • van der Spek, Rick A A
  • Shatunov, Aleksey
  • Cooper-Knock, Johnathan
  • Topp, Simon
  • Byrne, Ross
  • Gellera, Cinzia
  • López-Alonso, Victoria
  • Jones, Ashley R
  • Opie-Martin, Sarah
  • Vural, Atay
  • Campos, Yolanda
  • van Rheenen, Wouter
  • Kenna, Brendan
  • Van Eijk, Kristel R
  • Kenna, Kevin
  • Weber, Markus
  • Smith, Bradley
  • Fogh, Isabella
  • Silani, Vincenzo
  • Morrison, Karen E
  • Dobson, Richard
  • van Es, Michael A
  • McLaughlin, Russell L
  • Vourc'h, Patrick
  • Chio, Adriano
  • Corcia, Philippe
  • de Carvalho, Mamede
  • Gotkine, Marc
  • Panades, Monica P
  • Mora, Jesus S
  • Shaw, Pamela J
  • Landers, John E
  • Glass, Jonathan D
  • Shaw, Christopher E
  • Basak, Nazli
  • Hardiman, Orla
  • Robberecht, Wim
  • Van Damme, Philip
  • van den Berg, Leonard H
  • Veldink, Jan H
  • Al-Chalabi, Ammar
There is a strong genetic contribution to Amyotrophic lateral sclerosis (ALS) risk, with heritability estimates of up to 60%. Both Mendelian and small effect variants have been identified, but in common with other conditions, such variants only explain a little of the heritability. Genomic structural variation might account for some of this otherwise unexplained heritability. We therefore investigated association between structural variation in a set of 25 ALS genes, and ALS risk and phenotype. As expected, the repeat expansion in the C9orf72 gene was identified as associated with ALS. Two other ALS-associated structural variants were identified: inversion in the VCP gene and insertion in the ERBB4 gene. All three variants were associated both with increased risk of ALS and specific phenotypic patterns of disease expression. More than 70% of people with respiratory onset ALS harboured ERBB4 insertion compared with 25% of the general population, suggesting respiratory onset ALS may be a distinct genetic subtype.
Repisalud
Publication Artículo científico (JournalArticle)

Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data

  • Al Khleifat, Ahmad
  • Iacoangeli, Alfredo
  • Jones, Ashley R
  • van Vugt, Joke J F A
  • Moisse, Matthieu
  • Shatunov, Aleksey
  • Zwamborn, Ramona A J
  • van der Spek, Rick A A
  • Cooper-Knock, Johnathan
  • Topp, Simon
  • van Rheenen, Wouter
  • Kenna, Brendan
  • Van Eijk, Kristel R
  • Kenna, Kevin
  • Byrne, Ross
  • López-Alonso, Victoria
  • Opie-Martin, Sarah
  • Vural, Atay
  • Campos, Yolanda
  • Weber, Markus
  • Smith, Bradley
  • Fogh, Isabella
  • Silani, Vincenzo
  • Morrison, Karen E
  • Dobson, Richard
  • van Es, Michael A
  • McLaughlin, Russell L
  • Vourc'h, Patrick
  • Chio, Adriano
  • Corcia, Philippe
  • de Carvalho, Mamede
  • Gotkine, Marc
  • Povedano Panades, Monica
  • Mora, Jesus S
  • Shaw, Pamela J
  • Landers, John E
  • Glass, Jonathan D
  • Shaw, Christopher E
  • Basak, Nazli
  • Hardiman, Orla
  • Robberecht, Wim
  • Van Damme, Philip
  • van den Berg, Leonard H
  • Veldink, Jan H
  • Al-Chalabi, Ammar
Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the loss of upper and lower motor neurons, leading to progressive weakness of voluntary muscles, with death following from neuromuscular respiratory failure, typically within 3 to 5 years. There is a strong genetic contribution to ALS risk. In 10% or more, a family history of ALS or frontotemporal dementia is obtained, and the Mendelian genes responsible for ALS in such families have now been identified in about 50% of cases. Only about 14% of apparently sporadic ALS is explained by known genetic variation, suggesting that other forms of genetic variation are important. Telomeres maintain DNA integrity during cellular replication, differ between sexes, and shorten naturally with age. Sex and age are risk factors for ALS and we therefore investigated telomere length in ALS. Methods: Samples were from Project MinE, an international ALS whole genome sequencing consortium that includes phenotype data. For validation we used donated brain samples from motor cortex from people with ALS and controls. Ancestry and relatedness were evaluated by principal components analysis and relationship matrices of DNA microarray data. Whole genome sequence data were from Illumina HiSeq platforms and aligned using the Isaac pipeline. TelSeq was used to quantify telomere length using whole genome sequence data. We tested the association of telomere length with ALS and ALS survival using Cox regression. Results: There were 6,580 whole genome sequences, reducing to 6,195 samples (4,315 from people with ALS and 1,880 controls) after quality control, and 159 brain samples (106 ALS, 53 controls). Accounting for age and sex, there was a 20% (95% CI 14%, 25%) increase of telomere length in people with ALS compared to controls (p = 1.1 × 10-12), validated in the brain samples (p = 0.03). Those with shorter telomeres had a 10% increase in median survival (p = 5.0×10-7). Although there was no difference in telomere length between sporadic ALS and familial ALS (p=0.64), telomere length in 334 people with ALS due to expanded C9orf72 repeats was shorter than in those without expanded C9orf72 repeats (p = 5.0×10-4). Discussion: Although telomeres shorten with age, longer telomeres are a risk factor for ALS and worsen prognosis. Longer telomeres are associated with ALS.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis

  • Al Khleifat, Ahmad
  • Iacoangeli, Alfredo
  • Vugt, Joke J. F. A. van
  • Bowles, Harry
  • Moisse, Matthieu
  • Zwamborn, Ramona A. J.
  • Spek, Rick A. A. van der
  • Shatunov, Aleksey
  • Cooper-Knock, Johnathan
  • Topp, Simon
  • Byrne, Ross
  • Gellera, Cinzia
  • López, Victoria
  • Jones, Ashley R.
  • Opie Martin, Sarah
  • Vural, Atay
  • Campos, Yolanda
  • Rheenen, Wouter van
  • Kenna, Brendan
  • Eijk, Kristel R. van
  • Kenna, Kevin
  • Weber, Markus
  • Smith, Bradley
  • Fogh, Isabella
  • Silani, Vincenzo
  • Morrison, Karen E.
  • Dobson, Richard
  • Es, Michael A. van
  • Mclaughlin, Russell L.
  • Vourc’h, Patrick
  • Chio, Adriano
  • Corcia, Philippe
  • Carvalho, Mamede de
  • Gotkine, Marc
  • Panades, Monica P.
  • Mora, Jesus S.
  • Shaw, Pamela J.
  • Landers, John E.
  • Glass, Jonathan D.
  • Shaw, Christopher E.
  • Basak, Nazli
  • Hardiman, Orla
  • Robberecht, Wim
  • Damme, Philip van
  • Berg, Leonard H. van der
  • Veldink, Jan H.
  • Al Chalabi, Ammar
There is a strong genetic contribution to Amyotrophic lateral sclerosis (ALS) risk, with heritability estimates of up to 60%. Both Mendelian and small effect variants have been identified, but in common with other conditions, such variants only explain a little of the heritability. Genomic structural variation might account for some of this otherwise unexplained heritability. We therefore investigated association between structural variation in a set of 25 ALS genes, and ALS risk and phenotype. As expected, the repeat expansion in the C9orf72 gene was identified as associated with ALS. Two other ALS-associated structural variants were identified: inversion in the VCP gene and insertion in the ERBB4 gene. All three variants were associated both with increased risk of ALS and specific phenotypic patterns of disease expression. More than 70% of people with respiratory onset ALS harboured ERBB4 insertion compared with 25% of the general population, suggesting respiratory onset ALS may be a distinct genetic subtype.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis

  • Al Khleifat, Ahmad
  • Iacoangeli, Alfredo
  • Vugt, Joke J. F. A. van
  • Bowles, Harry
  • Moisse, Matthieu
  • Zwamborn, Ramona A. J.
  • Spek, Rick A. A. van der
  • Shatunov, Aleksey
  • Cooper-Knock, Johnathan
  • Topp, Simon
  • Byrne, Ross
  • Gellera, Cinzia
  • López, Victoria
  • Jones, Ashley R.
  • Opie Martin, Sarah
  • Vural, Atay
  • Campos, Yolanda
  • Rheenen, Wouter van
  • Kenna, Brendan
  • Eijk, Kristel R. van
  • Kenna, Kevin
  • Weber, Markus
  • Smith, Bradley
  • Fogh, Isabella
  • Silani, Vincenzo
  • Morrison, Karen E.
  • Dobson, Richard
  • Es, Michael A. van
  • Mclaughlin, Russell L.
  • Vourc’h, Patrick
  • Chio, Adriano
  • Corcia, Philippe
  • Carvalho, Mamede de
  • Gotkine, Marc
  • Panades, Monica P.
  • Mora, Jesus S.
  • Shaw, Pamela J.
  • Landers, John E.
  • Glass, Jonathan D.
  • Shaw, Christopher E.
  • Basak, Nazli
  • Hardiman, Orla
  • Robberecht, Wim
  • Damme, Philip van
  • Berg, Leonard H. van der
  • Veldink, Jan H.
  • Al Chalabi, Ammar
There is a strong genetic contribution to Amyotrophic lateral sclerosis (ALS) risk, with heritability estimates of up to 60%. Both Mendelian and small effect variants have been identified, but in common with other conditions, such variants only explain a little of the heritability. Genomic structural variation might account for some of this otherwise unexplained heritability. We therefore investigated association between structural variation in a set of 25 ALS genes, and ALS risk and phenotype. As expected, the repeat expansion in the C9orf72 gene was identified as associated with ALS. Two other ALS-associated structural variants were identified: inversion in the VCP gene and insertion in the ERBB4 gene. All three variants were associated both with increased risk of ALS and specific phenotypic patterns of disease expression. More than 70% of people with respiratory onset ALS harboured ERBB4 insertion compared with 25% of the general population, suggesting respiratory onset ALS may be a distinct genetic subtype.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A multicentre validation study of the diagnostic value of plasma neurofilament light

  • Ashton, Nicholas J.|||0000-0002-3579-8804
  • Janelidze, Shorena
  • Al Khleifat, Ahmad|||0000-0002-7406-9831
  • Leuzy, Antoine
  • van der Ende, Emma L.|||0000-0003-2570-8796
  • Karikari, Thomas K.|||0000-0003-1422-4358
  • Benedet, AndreaL.
  • Pascoal, Tharick A.
  • Lleó, Alberto|||0000-0002-2568-5478
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Galimberti, Daniela|||0000-0002-9284-5953
  • Bonanni, Laura
  • Pilotto, Andrea|||0000-0003-2029-6606
  • Padovani, Alessandro|||0000-0002-0119-3639
  • Lycke, Jan|||0000-0002-7891-8466
  • Novakova, Lenka
  • Axelsson, Markus
  • Velayudhan, Latha|||0000-0002-7712-930X
  • Rabinovici, Gil D.
  • Miller, Bruce L.|||0000-0002-2152-4220
  • Pariante, Carmine M.|||0000-0002-9132-5091
  • Nikkheslat, Naghmeh|||0000-0002-9427-6715
  • Resnick, Susan M.
  • Thambisetty, Madhav
  • Schöll, Michael|||0000-0001-7800-1781
  • Fernández-Eulate, Gorka|||0000-0003-1112-7464
  • Gil-Bea, Francisco J.
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • Al-Chalabi, Ammar|||0000-0002-4924-7712
  • Rosa-Neto, Pedro|||0000-0001-9116-1376
  • Strydom, Andre
  • Svenningsson, Per
  • Stomrud, Erik
  • Santillo, Alexander
  • Aarsland, Dag|||0000-0001-6314-216X
  • van Swieten, John C.
  • Palmqvist, Sebastian|||0000-0002-9267-1930
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Blennow, Kaj|||0000-0002-1890-4193
  • Hye, Abdul|||0000-0003-2237-4823
  • Hansson, Oskar|||0000-0001-8467-7286
Increased cerebrospinal fluid neurofilament light (NfL) is a recognized biomarker for neurodegeneration that can also be assessed in blood. Here, we investigate plasma NfL as a marker of neurodegeneration in 13 neurodegenerative disorders, Down syndrome, depression and cognitively unimpaired controls from two multicenter cohorts: King's College London (n = 805) and the Swedish BioFINDER study (n = 1,464). Plasma NfL was significantly increased in all cortical neurodegenerative disorders, amyotrophic lateral sclerosis and atypical parkinsonian disorders. We demonstrate that plasma NfL is clinically useful in identifying atypical parkinsonian disorders in patients with parkinsonism, dementia in individuals with Down syndrome, dementia among psychiatric disorders, and frontotemporal dementia in patients with cognitive impairment. Data-driven cut-offs highlighted the fundamental importance of age-related clinical cut-offs for disorders with a younger age of onset. Finally, plasma NfL performs best when applied to indicate no underlying neurodegeneration, with low false positives, in all age-related cut-offs.